Cholinesterase inhibitors and memantine in more advanced Alzheimer’s disease: the debate continues

ISSN： 1745-509X

Source： Aging Health, Vol.8, Iss.3, 2012-06, pp. : 233-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Memantine in the treatment of Alzheimer’s disease

By Porsteinsson Anton P Cosman Kelly M

Aging Health, Vol. 2, Iss. 6, 2006-12 ,pp. : 891-904

Future Medicine

Access to resources Recommend Favorite

Memantine: a treatment for Alzheimer’’s disease with a new formulation

By Makino Kelly M Porsteinsson Anton P

Aging Health, Vol. 7, Iss. 3, 2011-06 ,pp. : 349-362

Future Medicine

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors for Alzheimer’s disease

By Geldmacher David S

Aging Health, Vol. 3, Iss. 4, 2007-08 ,pp. : 483-494

Future Medicine

Access to resources Recommend Favorite

Aggressive Behavior in Advanced Alzheimer´s Disease

The International Journal of Aging and Society, Vol. 5, Iss. 3, 2015-01 ,pp. : 15-21

Common Ground Publishing

Access to resources Recommend Favorite

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model

By Hyde Christopher Peters Jaime Bond Mary Rogers Gabriel Hoyle Martin Anderson Rob Jeffreys Mike Davis Sarah Thokala Praveen Moxham Tiffany

Age and Ageing, Vol. 42, Iss. 1, 2013-01 ,pp. : 14-20

Oxford University Press

Access to resources Recommend Favorite